Livforsakringsbolaget Skandia, Omsesidigt Vertex Pharmaceuticals Inc Transaction History

Livforsakringsbolaget Skandia, Omsesidigt

$1.72 Billion
Q3 2024

A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 2,180 shares of VRTX stock, worth $866,048. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,180

Previous 21,865 90.03%

Holding current value

$866,048

Previous $10.2 Million 90.12%

% of portfolio

0.06%

Previous 0.84%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$460.0 - $505.78 $9.06 Million - $9.96 Million	-19,685 Reduced 90.03%	2,180 $1.01 Million
Q2 2024 Jul 15, 2024	SELL	$392.81 - $485.53 $78,562 - $97,106	-200 Reduced 0.91%	21,865 $10.2 Million
Q4 2023 Jan 31, 2024	BUY	$343.0 - $410.68 $88,494 - $105,955	258 Added 1.18%	22,065 $8.98 Million
Q3 2023 Oct 20, 2023	BUY	$338.18 - $362.46 $1.56 Million - $1.67 Million	4,620 Added 26.88%	21,807 $7.58 Million
Q2 2023 Jul 06, 2023	SELL	$314.42 - $351.91 $534,514 - $598,247	-1,700 Reduced 9.0%	17,187 $6.05 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $878,013 - $1 Million	3,100 Added 19.64%	18,887 $5.95 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $684,575 - $763,824	-2,500 Reduced 13.67%	15,787 $4.57 Million
Q2 2022 Aug 16, 2022	SELL	$234.96 - $292.55 $140,976 - $175,530	-600 Reduced 3.18%	18,287 $5.15 Million
Q1 2022 Jun 21, 2022	BUY	$221.42 - $260.97 $774,970 - $913,395	3,500 Added 22.75%	18,887 $4.93 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $265,515 - $335,175	-1,500 Reduced 8.88%	15,387 $3.38 Million
Q3 2021 Oct 28, 2021	SELL	$181.39 - $202.99 $72,556 - $81,196	-400 Reduced 2.31%	16,887 $3.06 Million
Q2 2021 Jul 13, 2021	BUY	$187.49 - $221.1 $206,239 - $243,210	1,100 Added 6.8%	17,287 $3.49 Million
Q1 2021 May 07, 2021	BUY	$207.02 - $241.31 $393,338 - $458,489	1,900 Added 13.3%	16,187 $3.48 Million
Q4 2020 Mar 02, 2021	BUY	$207.01 - $276.09 $621,030 - $828,269	3,000 Added 26.58%	14,287 $3.38 Million
Q3 2020 Nov 09, 2020	BUY	$255.65 - $303.1 $554,760 - $657,727	2,170 Added 23.8%	11,287 $3.07 Million
Q1 2020 Apr 22, 2020	BUY	$199.77 - $247.81 $179,793 - $223,029	900 Added 10.95%	9,117 $2.17 Million
Q4 2019 Jan 28, 2020	SELL	$166.71 - $223.91 $150,039 - $201,519	-900 Reduced 9.87%	8,217 $1.8 Million
Q2 2019 Jul 19, 2019	BUY	$164.61 - $190.37 $49,383 - $57,111	300 Added 3.4%	9,117 $1.67 Million
Q1 2019 May 09, 2019	BUY	$163.73 - $194.7 $1.07 Million - $1.28 Million	6,550 Added 288.93%	8,817 $1.62 Million
Q3 2018 Oct 26, 2018	SELL	$167.73 - $192.74 $385,779 - $443,302	-2,300 Reduced 50.36%	2,267 $437,000
Q2 2018 Jul 10, 2018	BUY	$145.72 - $169.96 $102,004 - $118,972	700 Added 18.1%	4,567 $776,000
Q4 2017 Jan 18, 2018	SELL	$137.28 - $155.55 $123,552 - $139,995	-900 Reduced 18.88%	3,867 $580,000
Q3 2017 Oct 12, 2017	BUY	$148.13 - $162.24 $706,135 - $773,398	4,767	4,767 $725,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $102B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

News

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.

Account

Livforsakringsbolaget Skandia, Omsesidigt Vertex Pharmaceuticals Inc Transaction History